Medicamen Biotech Share Price (MEDICAMEQ)
Check the latest share price of Medicamen Biotech, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
Medicamen Biotech Stock Performance
Get live Medicamen Biotech share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹410.5Day's Price Range₹419.2552 Week's Low
52 Week's High
₹375.0552-Week Price Range₹630
| Returns % | |
| 1 Month Return | -6.89 % |
| 3 Month Return | -0.86 % |
| 1 Year Return | -13.89 % |
| 3 Year Return | -34.7 % |
| 5 Year Return | -25.23 % |
| Market Stats | |
| Previous Close | ₹418.60 |
| Open | ₹415.00 |
| Volume | 29.17K |
| Upper Circuit | ₹502.30 |
| Lower Circuit | ₹334.90 |
Medicamen Biotech Fundamentals & Key Indicators
Check Medicamen Biotech market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹559.81 Cr
Return on Equity (ROE)
6.6
PE Ratio (TTM)
80.77
Return on capital employed (ROCE)
9.76
Industry PE ratio
57.39
Beta (LTM)
1.39
P/B Ratio
2.33
Dividend Yield
0.26
PEG Ratio
-33.8
Quarterly Earnings Growth YOY
-8.82
EPS (TTM)
7.47
Sector
Pharmaceuticals
Book Value
162.79
Technical Analysis
Bearish
View Technical Analysis
How to invest in Medicamen Biotech?
Investing in Medicamen Biotech is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Medicamen Biotech or MEDICAMEQ on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Medicamen Biotech or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Medicamen Biotech with just a few clicks!
Medicamen Biotech Stock's Interest Amongst Investors
Medicamen Biotech Valuation
Track how Medicamen Biotech P/E has moved over time to understand its valuation trends.
Medicamen Biotech in the last 5 years
Lowest (41.41x)
March 13, 2024
Industry (57.39x)
June 13, 2025
Today (80.77x)
June 13, 2025
Highest (132.87x)
December 6, 2024
Today’s Price to Earnings Ratio: 80.77x
Medicamen Biotech Financial Results
Get the annual and quarterly financial summary of Medicamen Biotech, including revenue, profit, loss and more.
Medicamen Biotech Earnings and Dividends
View detailed summary of the earnings and dividend history of Medicamen Biotech.
Medicamen Biotech Ltd Earnings Results
Medicamen Biotech Ltd’s net profit jumped 13.62% since last year same period to ₹2.42Cr in the Q4 2024-2025. On a quarterly growth basis, Medicamen Biotech Ltd has generated -30.26% fall in its net profits since last 3-months.
Read More about Earnings ResultsMedicamen Biotech Ltd Dividends May,2024
In the quarter ending March 2024, Medicamen Biotech Ltd has declared dividend of ₹1 - translating a dividend yield of 0.48%.
Read More about Dividends
Medicamen Biotech Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Medicamen Biotech.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 40.46% | ||
| Foreign Institutions | 0.22% | 94.01 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 58.62% | 4.71 | |
| Others | 0.7% |
Medicamen Biotech vs Peers
Compare market cap, revenue, PE, and other key metrics of Medicamen Biotech with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 559.81 | -5.05% | 0.57 | 9 | 179 | |
| NA | 6.24 | 5.19% | 5.69 | NA | NA | |
| NA | 81.58 | 58.65% | 0.51 | 1 | 40 | |
| NA | 1,949.06 | 25.81% | 0.51 | 58 | 630 | |
| NA | 69.91 | 6.88% | 0.78 | 2 | 45 |
Medicamen Biotech News & Key Events
Latest news and events in one place to help you make informed investing decisions in Medicamen Biotech.
Medicamen Biotech Secures USFDA Approval for Bortezomib - 03 Jun, 2025
Medicamen Biotech received its first ANDA approval from the USFDA for Bortezomib for Injection, enhancing its product portfolio and commitment to quality standards. Despite a decline in revenue, the approval signifies a strategic move into regulated markets.
Insights on Medicamen Biotech Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 0.12% to 0.22% in Apr 2025 quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 55.98% to 58.62% in Apr 2025 quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 165.8%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 59.2%
NEGATIVE IMPACTPromoter Holding Down
Promoters have decreased holdings from 43.16% to 40.46% in Apr 2025 quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, MEDICAMEQ stock has moved down by -6.9%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 45.28 Cr → 34.84 Cr (in ₹), with an average decrease of 23.1% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 3.47 Cr → 2.42 Cr (in ₹), with an average decrease of 30.3% per quarter
About Medicamen Biotech
Revenue: ₹29.61Cr as on March 2025 (Q4 FY25)
Net Profit: ₹1.86Cr as on March 2025 (Q4 FY25)
Listing date: 27 Oct, 2021
Chairperson Name: Rahul Bishnoi
| Organisation | Medicamen Biotech Ltd |
| Industry | Pharmaceuticals |
| CEO | Rahul Bishnoi |
| E-voting on shares | Click here to vote |
FAQs
What is Medicamen Biotech share price today?
Medicamen Biotech share price today stands at ₹412.75, Open: ₹415, Previous Close: ₹418.6, High: ₹419.25, Low: ₹410.5, 52 Week High: ₹630, 52 Week Low: ₹375.05.
What is today's traded volume of Medicamen Biotech?
Today's traded volume of Medicamen Biotech is 29.17K. Which means that 29.17K shares of Medicamen Biotech were bought and sold on the stock market during today's trading session.
What is Medicamen Biotech's market cap today?
Today's market capitalisation of Medicamen Biotech is ₹559.81 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Medicamen Biotech?
Medicamen Biotech’s 52 week high is ₹630 and 52 week low is ₹375.05. The current share price of Medicamen Biotech is ₹412.75, which is -34.48% down from its 52 week high and 10.05% up from its 52 week low.